AI Engines For more Details: Perplexity Kagi Labs You
Blood Pressure Management: Beets are rich in nitrates, which are converted into nitric oxide in the body. Nitric oxide helps to relax and dilate blood vessels, which can lead to lower blood pressure. Consuming beetroot or beet juice may help in managing hypertension.
Improved Athletic Performance: The nitric oxide produced from dietary nitrates in beets may also enhance athletic performance by improving blood flow and oxygen delivery to muscles. Some studies suggest that beet juice supplementation may improve exercise endurance and performance.
Enhanced Cognitive Function: Nitric oxide production from beet consumption may also have positive effects on brain health. Research suggests that beet juice may improve cognitive function, particularly in older adults, by increasing blood flow to the brain.
Improved Endurance and Stamina: The nitrates in beet juice have been shown to improve endurance during physical activity by enhancing oxygen utilization efficiency. This can benefit athletes and individuals engaging in endurance exercises such as running, cycling, or swimming.
Potential Anti-inflammatory Effects: Beets contain betalains, which are pigments with antioxidant and anti-inflammatory properties. These compounds may help reduce inflammation in the body, which is associated with various chronic diseases such as heart disease, arthritis, and certain types of cancer.
Support for Liver Health: Beets are rich in antioxidants and phytonutrients that may support liver function and detoxification processes. Consuming beet juice may help promote liver health and protect against liver damage.
Digestive Health: Beets are a good source of dietary fiber, which can promote digestive regularity and support gut health. Fiber also helps to regulate blood sugar levels and may aid in weight management.
Potential Cancer Prevention: Some studies suggest that the antioxidants and phytonutrients found in beets may have anti-cancer properties and could help reduce the risk of certain types of cancer, although more research is needed in this area.
Rank | Probiotic | Impact |
---|---|---|
species | Bifidobacterium adolescentis | Increases |
species | Bifidobacterium bifidum | Increases |
species | Bifidobacterium breve | Increases |
species | Bifidobacterium catenulatum | Increases |
species | Bifidobacterium longum | Increases |
species | Bifidobacterium pseudocatenulatum | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.6 | 0.6 | |
ADHD | 1.3 | -1.3 | |
Allergic Rhinitis (Hay Fever) | 1.2 | 1.2 | |
Allergies | 0.5 | 0.6 | -0.2 |
Allergy to milk products | 0.9 | 0.9 | |
Alzheimer's disease | 0.9 | 0.9 | 0 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | -0.6 | |
Ankylosing spondylitis | 0.6 | -0.6 | |
Asthma | 0.3 | 0.6 | -1 |
Atherosclerosis | 0.6 | -0.6 | |
Atrial fibrillation | 0.6 | 0.6 | 0 |
Autism | 1.3 | 0.6 | 1.17 |
Brain Trauma | 0.9 | -0.9 | |
Carcinoma | 0.6 | 0.6 | 0 |
Celiac Disease | 1.2 | 0.2 | 5 |
Cerebral Palsy | 0.6 | -0.6 | |
Chronic Fatigue Syndrome | 0.6 | 0.6 | 0 |
Colorectal Cancer | 0.6 | 0.6 | 0 |
COVID-19 | 1.2 | 1 | 0.2 |
Crohn's Disease | 0.9 | 0.6 | 0.5 |
cystic fibrosis | 0.6 | 0.6 | |
Depression | 1 | 1.7 | -0.7 |
Dermatomyositis | 0.6 | 0.6 | |
Eczema | 0.9 | 0.9 | |
Endometriosis | 0.6 | -0.6 | |
Epilepsy | 0.6 | 0.6 | 0 |
Fibromyalgia | 0.6 | 0.6 | |
Functional constipation / chronic idiopathic constipation | 0.6 | 0.8 | -0.33 |
gallstone disease (gsd) | 0.6 | 0.6 | |
Generalized anxiety disorder | 0.8 | 0.8 | |
Graves' disease | 0.6 | -0.6 | |
Hashimoto's thyroiditis | 0.6 | 0.6 | 0 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.3 | 0.6 | -1 |
hyperglycemia | 0.6 | 0.6 | |
Hyperlipidemia (High Blood Fats) | 0.6 | -0.6 | |
hypertension (High Blood Pressure | 0.6 | 0.6 | 0 |
Hypothyroidism | 0.6 | 0.6 | |
IgA nephropathy (IgAN) | 0.6 | 0.6 | |
Inflammatory Bowel Disease | 0.8 | 0.6 | 0.33 |
Irritable Bowel Syndrome | 0.6 | 0.6 | 0 |
Liver Cirrhosis | 0.6 | 0.6 | 0 |
Long COVID | 1.2 | 1.1 | 0.09 |
ME/CFS with IBS | 0.6 | 0.6 | |
ME/CFS without IBS | 0.6 | 0.6 | |
Menopause | 0.2 | 0.4 | -1 |
Metabolic Syndrome | 1.6 | 1.1 | 0.45 |
Mood Disorders | 1.3 | 1.7 | -0.31 |
Multiple Sclerosis | 0.8 | -0.8 | |
Multiple system atrophy (MSA) | 0.8 | 0.8 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.2 | 1.2 | |
NonCeliac Gluten Sensitivity | 0.6 | 0.6 | |
Obesity | 0.8 | 0.6 | 0.33 |
obsessive-compulsive disorder | 0.8 | 0.8 | |
Osteoarthritis | 0.2 | 0.2 | |
Parkinson's Disease | 0.2 | 1.1 | -4.5 |
Polycystic ovary syndrome | 0.6 | 0.6 | |
Postural orthostatic tachycardia syndrome | 0.6 | 0.6 | |
Premenstrual dysphoric disorder | 0.6 | -0.6 | |
Psoriasis | 0.6 | -0.6 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.6 | 0.9 | -0.5 |
Rosacea | 0.6 | -0.6 | |
Schizophrenia | 0.9 | 1 | -0.11 |
Sjögren syndrome | 0.8 | 0.8 | |
Sleep Apnea | 0.6 | -0.6 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.2 | 0.2 | |
Stress / posttraumatic stress disorder | 0.6 | 0.6 | 0 |
Systemic Lupus Erythematosus | 0.6 | 0.6 | |
Tic Disorder | 0.6 | 0.6 | |
Type 1 Diabetes | 0.4 | 0.4 | |
Type 2 Diabetes | 1 | 1.1 | -0.1 |
Ulcerative colitis | 0.8 | 0.9 | -0.13 |
Unhealthy Ageing | 0.6 | 0.6 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.